J. Goldman & CO LP Aurinia Pharmaceuticals Inc. Call Options Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$7.13 - $9.49 $577,530 - $768,690
81,000 Added 120.0%
148,500 $1.34 Million
Q3 2023

Nov 14, 2023
BUY
$7.77 - $12.27 $524,475 - $828,225
67,500 New
67,500 $524,000
Q1 2023

May 15, 2023
BUY
$5.94 - $11.27 $361,152 - $685,216
60,800 New
60,800 $666,000
Q2 2020

Aug 14, 2020
BUY
$14.12 - $18.33 $988,400 - $1.28 Million
70,000 New
70,000 $1.14 Million

Others Institutions Holding AUPH

# of Institutions
209
Shares Held
58.7M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email